Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|September 1, 1995
Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centresM Hjorth, E Holmberg, S Rödjer, et al.
Controlled Clinical Trials|October 1, 1996
Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myelomaM Hjorth, E Holmberg, S Rödjer, et al.
Journal of Surgical Oncology|December 1, 1986
Primary gastrointestinal lymphoma incidence, clinical presentation, and surgical approachH Bäck, B Gustavsson, B Ridell, et al.
Acta Medica Scandinavica|January 1, 1988
Pneumococcal vaccination in splenectomized patients with hematological disordersR Lindblad, B Kaijser, B Magnusson, et al.
Acta Dermato-Venereologica|May 1, 1994
A follow-up study of bone marrow chromosomes and in vitro colony growth in patients with mastocytosisB Swolin, S Rödjer, A al-Obaidy, et al.
The American Journal of Medicine|October 1, 1991
M-component with reactivity against actin associated with thrombotic thrombocytopenic purpuraH Bäck, G Nilsson, G K Hansson, et al.
British Journal of Haematology|February 1, 1990
Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western SwedenM Hjorth, L Hellquist, E Holmberg, et al.
European Journal of Haematology|May 5, 1999
Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG)M Hjorth, E Holmberg, S Rödjer, et al.
European Journal of Haematology|February 1, 1993
Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western SwedenM Hjorth, L Hellquist, E Holmberg, et al.
Lakartidningen|January 5, 2002
[Control of methicillin resistant staphylococci at the Sahlgrenska hospital. Successful control program against MRSA outbreak]E Haglind, A Brantervik, S Friman, et al.
Pageof 4